Issues in the Design and Interpretation of Chronic Toxicity and Carcinogenicity Studies in Rodents: Approaches to Dose Selection

REFERENCES

• Aardema M. J., MacGregor J. T. Toxicology and genetic toxicology in the new era of “toxicogenomics”: impact of “-omics” technologies. Mutat. Res. 2002; 499(1)13–25
   PubMed Web of Science ®Google Scholar
• Adair L. S., Kuzawa C. W., Borja J. Maternal energy stores and diet composition during pregnancy program adolescent blood pressure. Circulation 2001; 104(9)1034–1039
   PubMed Web of Science ®Google Scholar
• Ahmed A. E., Anders M. W. Metabolism of dihalomethanes to formaldehyde and inorganic halide. I. In vitro studies. Drug Metab. Dispos. 1978; 4: 357–361
   Google Scholar
• Allaben W., Chou M., Pegram R., Leakey J., Feuers R., Duffy P., Turturro A., Hart R. Modulation of toxicity and carcinogenicity by caloric restriction. Korean J. Toxicol. 1990; 6(2)167–182
   Google Scholar
• Amin R. P., Vickers A. E., Sistare F., Thompson K. L., Roman R. J., Lawton M., Kramer J., Hamadeh H. K., Collins J., Grissom S., Bennett L., Tucker C. J., Wild S., Kind C., Oreffo V., Davis J. W., 2nd, Curtiss S., Naciff J. M., Cunningham M., Tennant R., Stevens J., Car B., Bertram T. A., Afshari C. A. Identification of putative gene based markers of renal toxicity. Environ. Health Perspect. 2004; 112(4)465–79
   PubMed Web of Science ®Google Scholar
• Amundson S. A., Fornace A. J., Jr. Gene expression profiles for monitoring radiation exposure. Radiat. Prot. Dosim. 2001; 97(1)11–16
   PubMedGoogle Scholar
• Amundson S. A., Fornace A. J., Jr. Monitoring human radiation exposure by gene expression profiling: possibilities and pitfalls. Health Phys. 2003; 85: 36–42
   PubMed Web of Science ®Google Scholar
• Andersen M. E., Green T., Frederick C. B., Bogdanffy M. S. Physiologically based pharmacokinetic (PBPK) models for nasal tissue dosimetry of organic esters: Assessing the state-of-knowledge and risk assessment applications with methyl methacrylate and vinyl acetate. Regul. Toxicol. Pharmacol. 2002; 36: 234–245
   PubMed Web of Science ®Google Scholar
• Andersen M. E., et al. Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds. Toxicol. Sci. 2000; 53: 159–172
   PubMed Web of Science ®Google Scholar
• Andersen M. E., Clewell H. J., III, Gargas M. L., Smith F. A., Reitz R. H. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 1987; 87: 185–205
   PubMed Web of Science ®Google Scholar
• Anyoshi N., Imaoka S., Nakayama K., et al. Comparison of the level of enzymes involved in drug metabolism between transgenic or gene-knockout and the parental mice. Toxicol. Pathol. 2001; 29(Suppl.)161–172
   PubMedGoogle Scholar
• Ashby J., Kier L., Wilson A. G., Green T., Lefevre P. A., Tinwell H., Willis G. A., Heydens W. F., Clapp M. J. Evaluation of the potential carcinogenicity and genetic toxicity to humans of the herbicide acetochlor. Hum. Exp. Toxicol. 1996; 15(9)702–735
   PubMedGoogle Scholar
• Baird S JS, Cohen J. T., Graham J. D., Shlyakhter A. I., Evans J. S. Noncancer risk assessment: A probabilistic alternative to current practice. Hum. Ecol. Risk Assess. 1996; 2: 78–99
   Web of Science ®Google Scholar
• Barton H. A., Pastoor T. P., Baetcke K., Chambers J. E., Diliberto J., Doerrer N. G., Driver J. H., Hastings C. E., Iyengar S., Krieger R., Stahl B., Timchalk C. The acquisition and application of absorption, distribution, metabolism, and excretion (ADME) data in agricultural chemical safety assessments. Crit. Rev. Toxicol. 2006; 36: 9–35
   PubMed Web of Science ®Google Scholar
• Barrow C. S. Respiratory and metabolic response of rats and mice to formalin vapor. Toxicology 1983; 28(4)357–359
   PubMedGoogle Scholar
• Bellmann B., Muhle H., Creutzenberg O., Mermelstein R. Irreversible pulmonary changes induced in rat lung by dust overload. Environ. Health Perspect. 1992; 97: 189–191
   PubMed Web of Science ®Google Scholar
• Carcinogenicity Testing, I. Berenblum. UICC Technical Report Series, No. 2., International Union Against Cancer, Geneva 1969
   Google Scholar
• Bogdanffy M. S., Sarangapani R., Plowchalk D. R., Jarabek A., Andersen M. E. A biologically based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity. Toxicol. Sci. 1999; 51: 19–35
   PubMed Web of Science ®Google Scholar
• Boley S. E., Anderson E. E., French J. E., Donehower L. A., Walker D. B., Recio L. Loss of p53 in benzene-induced thymic lymphomas in p53+/− mice: Evidence of chromosomal recombination. Cancer Res. 2000; 60: 2831–2835
   PubMedGoogle Scholar
• Bucher J. R. Doses in rodent cancer studies: Sorting fact from fiction. Drug Metab. Rev. 2000; 32(2)153–163
   PubMed Web of Science ®Google Scholar
• Canman C. E. Replication checkpoint: Preventing mitotic catastrophe. Curr. Biol. 2001; 11: R121–124
   PubMedGoogle Scholar
• Casanova M., Morgan K. T., Gross E. A., Moss O. R., Heck H. d'A. DNA-protein cross-links and cell replication at specific sites in the nose of F344 rats exposed subchronically to formaldehyde. Fundam. Appl. Toxicol. 1994; 23: 525–536
   PubMedGoogle Scholar
• Casanova M., Morgan K. T., Steinhagen W. H., Everitt J. I., Popp J. A., Heck H. d'A. Covalent binding of inhaled formaldehyde to DNA in the respiratory tract of rhesus monkeys: Pharmacokinetics, rat-to-monkey interspecies scaling, and extrapolation to man. Fundam. Appl. Toxicol. 1991; 17: 409–428
   PubMedGoogle Scholar
• Chan A. O., Broaddus R. R., Houlihan P. S., Issa J. P., Hamilton S. R., Rashid A. CpG island methylation in aberrant crypt foci of the colorectum. Am. J. Pathol. 2002; 160(5)1823–1830
   PubMed Web of Science ®Google Scholar
• Chan P. K., Hayes A. W. Acute toxicity and eye irritancy. Principles and Methods of Toxicology, AW Hayes. Raven Press, New York 1994
   Google Scholar
• Chang J. C., Gross E. A., Swenberg J. A., Barrow C. S. Nasal cavity deposition, histopathology, and cell proliferation after single or repeated formaldehyde exposures in B6C3F1 mice and F-344 rats. Toxicol. Appl. Pharmacol. 1983; 68(2)161–176
   PubMed Web of Science ®Google Scholar
• Clewell H. J., Gearhart J. M., Gentry P. R., Covington T. R., VanLandingham C. B., Crump K. S., Shipp A. M. Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal. 1999; 19: 547–558
   PubMed Web of Science ®Google Scholar
• Clewell H. J., III. Incorporating biological information in quantitative risk assessment: An example with methylene chloride. Toxicology 1995; 102: 83–94
   PubMed Web of Science ®Google Scholar
• Cohen S. M. Cell proliferation and carcinogenesis. Drug Metab. Rev. 1998; 30(2)339–357
   PubMed Web of Science ®Google Scholar
• Cohen S. M., Ellwein L. B. Cell proliferation in carcinogenesis. Science 1990a; 249(4972)1007–1011
   PubMed Web of Science ®Google Scholar
• Cohen S. M., Ellwein L. B. Proliferative and genotoxic cellular effects in 2-acetylaminofluorene bladder and liver carcinogenesis: biological modeling of the ED01 study. Toxicol. Appl. Pharmacol. 1990b; 104(1)79–93
   PubMedGoogle Scholar
• Cohen S. M., Purtilo D. T., Ellwein L. B. Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis. Mod. Pathol. 1991; 4(3)371–82
   PubMedGoogle Scholar
• Colborn T., Clement C. Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton Scientific, Princeton, NJ 1992
   Google Scholar
• Colborn T., vom Saal F. S., Soto A. M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 1993; 101(5)378–384
   PubMed Web of Science ®Google Scholar
• Endogenous toxicants in foods derived from higher plants. Food Toxicology, J. Concon, J.M. Concon. Dekker, New York 1988; 281–405
   Google Scholar
• Conn C. A., Green F. H., Nikula K. J. Animal models of pulmonary infection in the compromised host: potential usefulness for studying health effects of inhaled particles. Inhal. Toxicol. 2000; 12(9)783–827
   PubMedGoogle Scholar
• Conolly R. B., Kimbell J. S., Janszen D. J., Schlosser P. M., Kalisak D., Preston J., Miller F. J. Human respiratory tract cancer risks of inhaled formaldehyde: Dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicol. Sci. 2004; 82: 279–296
   PubMed Web of Science ®Google Scholar
• Conolly R. B., Kimbell J. S., Janszen D. J., Schlosser P. M., Kalisak D., Preston J., Miller F. J. Biologically motivated computational modeling of formaldehyde in the F344 rat. Toxicol. Sci. 2003; 75: 432–447
   PubMed Web of Science ®Google Scholar
• Conolly R. B., Lilly P. D., Kimbell J. S. Simulation modeling of the tissue disposition of formaldehyde to predict nasal DNA-protein cross-links in Fischer 344 rats, rhesus monkeys, and humans. Environ. Health Perspect. 2000; 108(Suppl. 5)919–924
   PubMedGoogle Scholar
• Contrera J. F., Jacobs A. C., Prasana H. R., Mehta M., Schmidt W. J., De George J. A systemic exposure based alternative to maximum tolerated dose for carcinogenicity studies of human therapeutics. J. Am. Coll. Toxicol. 1995; 14: 1–10
   Google Scholar
• Cunningham M. L. Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutat Res. 1996; 365(1–3)59–69
   PubMed Web of Science ®Google Scholar
• de Serres F.J., Brockman H. E. Comparison of the spectra of genetic damage in formaldehyde-induced ad-3 mutations between DNA repair-proficient and -deficient heterokaryons of Neurospora crassa. Mutat. Res. 1999; 437: 151–163
   PubMed Web of Science ®Google Scholar
• Dieter M. P., Goehl T. J., Jameson C. W., Elwell M. R., Hildebrandt P. K., Yuan J. H. Comparison of the toxicity of citral in F344 rats and B6C3F1 mice when administrated by microencapsulation in feed or by corn-oil gavage. Food Chem. Toxicol. 1993; 31: 463–474
   PubMedGoogle Scholar
• Dietmaier W., Gansbauer S., Beyser K., Renke B., Hartmann A., Rummele P., Jauch K. W., Hofstadter F., Ruschoff J. Microsatellite instability in tumor and nonneoplastic colorectal cells from hereditary non-polyposis colorectal cancer and sporadic high microsatellite-instable tumor patients. Pathobiology 2000; 68(4–5)227–231
   PubMedGoogle Scholar
• Dillon A., Hsu A. L., Arantes-Oliveira N., Lehrer-Graiwer J., Hsin H., Graser A. G., Kamath R. S., Ahringer J., Kenyon C. Rates of behavior and aging specified by mitochondrial function during development. Science 2002; 298: 2398–2401
   PubMedGoogle Scholar
• Dixit R., Riviere J., Krishnan K., Andersen M. E. Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment. J. Toxicol. Environ. Health B 2003; 6(1)1–40
   PubMed Web of Science ®Google Scholar
• Doe J. E., Boobis A. R., Blacker A., Dellarco V., Doerrer N. G., Franklin C., Goodman J. I., Kronenberg J. M., Lewis R., McConnell E. E., Mercier T., Moretto A., Nolan C., Padilla S., Phang W., Solecki R., Tilbury L., van Ravenzwaay B., Wolf D. C. A tiered approach to systemic toxicity testing for agricultural chemical safety assessment. Crit. Rev. Toxicol. 2006; 36: 37–68
   PubMed Web of Science ®Google Scholar
• Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A., Butel J. S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992; 356: 215–221
   PubMed Web of Science ®Google Scholar
• Dourson M. L., Felter S. P., Robinson D. Evolution of science-based uncertainty factors in noncancer risk assessment. Regul. Toxicol. Pharmacol. 1996; 24: 108–120
   PubMed Web of Science ®Google Scholar
• Dragan Y., Bidlack W., Cohen S., Goldsworthy T., Hard G., Howard P., Riley R., Voss K. Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: Fumonisin B1 as an example. Toxicol. Sci. 2001; 61(1)6–17
   PubMedGoogle Scholar
• Dragan Y. P., Hully J., Baker K., Crow R., Mass M. J., Pitot H. C. Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis. Toxicology 1995a; 102(1–2)161–175
   PubMedGoogle Scholar
• Dragan Y., Teeguarden J., Campbell H., Hsia S., Pitot H. The quantification of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression. Cancer Lett. 1995b; 93(1)79–83
   Google Scholar
• ECETOC. Practical concepts for dose selection in chronic toxicity and carcinogenicity studies in rodents. ECETOC Monograph No. 25. European Centre for Ecotoxicology and Toxicology of Chemicals, Brussels YorkBelgium 1996
   Google Scholar
• EDSTAC (Endocrine Disruptor Screening and Testing Advisory Committee). Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC): Final Report. U.S. Environmental Protection Agency, Washington, DC 1998; 1
   Google Scholar
• Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., Ahr H. J. Characteristic expression profiles induced by genotoxic carcinogens in rat liver. Toxicol. Sci. 2004; 77: 19–34
   PubMed Web of Science ®Google Scholar
• Ellinger-Ziegelbauer H., Stuart B., Wahle B., Bomann W., Ahr H. J. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res. 2005; 575: 61–84
   PubMed Web of Science ®Google Scholar
• Elrick M. M., Kramer J. A., Alden C. L., Blomme E. A., Bunch R. T., Cabonce M. A., Curtiss S. W., Kier L. D., Kolaja K. L., Rodi C. P., Morris D. L. Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity. Toxicol. Pathol. 2005; 33: 118–126
   PubMedGoogle Scholar
• Euhus D. M., Cler L., Shivapurkar N., Milchgrub S., Peters G. N., Leitch A. M., Heda S., Gazdar A. F. Loss of heterozygosity in benign breast epithelium in relation to breast cancer risk. J. Natl. Cancer Inst. 2002; 94(11)858–860
   PubMedGoogle Scholar
• FDA. Guidance for industry: Carcinogenicity study protocol submissions. FDA Center for Drug Evaluation and Research (CDER), May. 2002, http://www.fda.gov/cder/guidance/4804fnl.pdf
   Google Scholar
• Federal Register. ICH S1B, Testing for carcinogenicity of pharmaceuticals. 1998; 63: 8983, February 23, 1998
   Google Scholar
• Feitelson M. A., Sun B., Satiroglu Tufan N. L., Liu J., Pan J., Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 2002; 21(16)2593–2604
   PubMed Web of Science ®Google Scholar
• Feo F., Pascale R. M., Simile M. M., De Miglio M. R., Muroni M. R., Calvisi D. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies. Crit. Rev. Oncol. 2000; 11(1)19–62
   Google Scholar
• Field J. K., Liloglou T., Xinarianos G., Prime W., Fielding P., Walshaw M. J., Turnbull L. Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer. Cancer Res. 1999; 59(11)2690–2695
   PubMed Web of Science ®Google Scholar
• Forsen T., Eriksson J., Tuomilehto J., Reunanen A., Osmond C., Barker D. The fetal and childhood growth of persons who develop type 2 diabetes. Ann. Intern. Med. 2000; 133(3)176–182
   PubMed Web of Science ®Google Scholar
• Frommel T. O., Zarling E. J. Chronic inflammation and cancer: Potential role of Bcl-2 gene family members as regulators of cellular antioxidant status. Med. Hypoth. 1999; 52(1)27–30
   PubMedGoogle Scholar
• Gad S., Weil C. S. Statistics and Experimental Design for Toxicologists. Telford Press, Caldwell, NJ 1986
   Google Scholar
• Gaylor D. W., Chen J. J., Kodell R. L. Experimental design of bioassays for screening and low dose extrapolation. Risk Anal. 1985; 5: 9–16
   PubMed Web of Science ®Google Scholar
• Gerrity T. R., Weaver R. A., Berntsen J., House D. E., O'Neil J. J. Extrathoracic and intrathoracic removal of O3 in tidal-breathing humans. J. Appl. Physiol. 1988; 65(1)393–400
   PubMedGoogle Scholar
• Gilmour M. I., Park P., Doerfler D., Selgrade M. K. Factors that influence the suppression of pulmonary antibacterial defenses in mice exposed to ozone. Exp. Lung Res. 1993a; 19(3)299–314
   PubMed Web of Science ®Google Scholar
• Gilmour M. I., Park P., Selgrade M. K. Ozone-enhanced pulmonary infection with Streptococcus zooepidemicus in mice. The role of alveolar macrophage function and capsular virulence factors. Am. Rev. Respir. Dis. 1993b; 147(3)753–760
   PubMedGoogle Scholar
• Gold D. R., Litonjua A., Schwartz J., Lovett E., Larson A., Nearing B., Allen G., Verrier M., Cherry R., Verrier R. Ambient pollution and heart rate variability. Circulation 2000; 101: 1267–1273
   PubMed Web of Science ®Google Scholar
• Gout P., Buckley A., Simms C., Bruchovsky N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)-cystine transporter; a new action for an old drug. Leukemia 2001; 15: 1633–1640
   PubMed Web of Science ®Google Scholar
• Grafstrom R. C., Hsu I. C., Harris C. C. Mutagenicity of formaldehyde in Chinese hamster lung fibroblasts: Synergy with ionizing radiation and N-nitroso-N-methylurea. Chem. Biol. Interact. 1993; 86: 41–49
   PubMed Web of Science ®Google Scholar
• Grasl-Kraupp B., Luebeck G., Wagner A., Low-Baselli A., de Gunst M., Waldhor T., Moolgavkar S., Schulte-Hermann R. Quantitative analysis of tumor initiation in rat liver: Role of cell replication and cell death (apoptosis). Carcinogenesis 2000; 21(7)1411–1421
   PubMedGoogle Scholar
• Green T., Lee R., Moore R. B., Ashby J., Willis G. A., Lund V. J., Clapp M. J. Acetochlor-induced rat nasal tumors: Further studies on the mode of action and relevance to humans. Regul. Toxicol. Pharmacol. 2000; 32(1)127–133
   PubMedGoogle Scholar
• Grimaldi P. A. Fatty acid regulation of gene expression. Curr. Opin. Clin. Nutr. Metab. Care 2001; 4: 433–437
   PubMed Web of Science ®Google Scholar
• Grose E. C., Richards J. H., Illing J. W., Miller F. J., Davies D. W., Graham J. A., Gardner D. E. Pulmonary host defense responses to inhalation of sulfuric acid and ozone. J. Toxicol. Environ. Health 1982; 10(3)351–362
   PubMed Web of Science ®Google Scholar
• Guan Y. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease. Minerva Urol. Nefrol. 2002; 54: 65–79
   PubMedGoogle Scholar
• Gulezian D., Jacobson-Kram D., McCullough B., Olson H., Recio L., Robinson D., Storer R., Tennant R., Ward J. M., Neumann D. A. Use of transgenic animals for carcinogenicity testing: Considerations and implications for risk assessment. Toxicol. Pathol. 2000; 28: 482–499
   PubMed Web of Science ®Google Scholar
• Hamadeh H. K., Bushel P., Paules R. d., Afshari C. A. Discovery in toxicology: mediation by gene expression array technology. J. Biochem. Mol. Toxicol. 2001; 15(5)231–242
   PubMedGoogle Scholar
• Hansen L. A., Tennant R. W. Follicular origin of epidermal papillomas in v-Ha-ras transgenic Tg·AC mouse skin. Proc. Natl. Acad. Sci. USA 1994; 91: 7822–7826
   PubMedGoogle Scholar
• Hart R. W., Freni S. C., Gaylor D. W., Gillette J. R., Lowry L. K., Ward J. M., Weisburger E. K., Lepore P., Turturro A. Final report of the Color Additive Scientific Review Panel. Risk Anal. 1986; 6(2)117–154
   PubMedGoogle Scholar
• Hart R., Dixit R., Seng J., Turturro A., Leakey J., Feuers R., Duffy P., Buffington C., Cowan G., Lewis S., Pipkin J., Li S. Adaptive role of caloric intake on degenerative disease processes. Toxicol. Sci. 1999; 52(Suppl. 2)3–12
   PubMedGoogle Scholar
• Haseman J. K., Young E., Eustis S. L., Haley J. R. Body weight-tumor incidence correlations in long-term rodent carcinogenicity studies. Toxicol. Pathol. 1997; 25(3)256–263
   PubMedGoogle Scholar
• Hatch G. E., Slade R., Harris L. P., McDonnell W. F., Devlin R. B., Koren H. S., Costa D. L., McKee J. Ozone dose and effect in humans and rats. A comparison using oxygen-18 labeling and bronchoalveolar lavage. Am. J. Respir. Crit. Care Med. 1994; 150(3)676–683
   PubMed Web of Science ®Google Scholar
• Hattis D., Baird S., Goble R. A straw man proposal for a quantitative definition of the RfD. Drug Chem. Toxicol. 2002; 25: 403–436
   PubMed Web of Science ®Google Scholar
• Hattis D., Anderson E. What should be the implications of uncertainty, variability, and inherent ‘biases’/‘conservatism’ for risk management decision making?. Risk Anal. 1999; 19: 95–107
   Web of Science ®Google Scholar
• Hattis D., Banati P., Goble R. Distributions of individual susceptibility among humans for toxic effects–For what fraction of which kinds of chemicals and effects does the traditional 10-fold factor provide how much protection?. Ann. NY Acad. Sci. 1999; 895: 286–316
   PubMed Web of Science ®Google Scholar
• Hattis D. Human interindividual variability in susceptibility to toxic effects–from annoying detail to a central determinant of risk. Toxicology 1996; 111: 5–14
   PubMed Web of Science ®Google Scholar
• Heck H.d'A., Casanova M. Pharmacodynamics of formaldehyde: Applications of a model for the arrest of DNA replication by DNA-protein cross-links. Toxicol. Appl. Pharmacol. 1999; 160: 86–100
   PubMedGoogle Scholar
• Hill D. J., Duvillie B. Pancreatic development and adult diabetes. Pediatr. Res. 2000; 48(3)269–274
   PubMedGoogle Scholar
• Hoel D. G., Portier C. J. Nonlinearity of dose-response functions for carcinogenicity. Environ. Health Perspect. 1994; 102(Suppl.1)109–113
   PubMed Web of Science ®Google Scholar
• Hong M. Y., Chapkin R. S., Morris J. S., Wang N., Carroll R. J., Turner N. D., Chang W. C., Davidson L. A., Lupton J. R. Anatomical site-specific response to DNA damage is related to later tumor development in the rat azoxymethane colon carcinogenesis model. Carcinogenesis 2001; 22(11)1831–1835
   PubMedGoogle Scholar
• Hu T., Gibson D. P., Carr G. J., Torontali S. M., Tiesman J. P., Chaney J. G., Aardema M. J. Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins. Mutat. Res. 2004; 549: 5–27
   PubMed Web of Science ®Google Scholar
• Huikuri H. V., Makikallio T., Airaksinen J., Mitrani R., Castellanos A., Myerburg R. J. Measurement of heart rate variability: A clinical tool or a research toy. J. Am. Coll. Cardiol. 1999; 34: 1878–1883
   PubMed Web of Science ®Google Scholar
• Huikuri H. V., Makikallio T. H., Airaksinen K EJ, Seppanen T., Puukka P., Haiha I. J., Sourander L. B. Power-law relationship of heart rate variability as a predictor of mortality in the elderly. Circulation 1998; 97: 2031–2036
   PubMed Web of Science ®Google Scholar
• Hurley P. M. Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environ. Health Perspect. 1998; 106(8)437–445
   PubMed Web of Science ®Google Scholar
• IARC (International Agency for Research on Cancer). Predictive value of rodent forestomach and gastric neuroendocrine tumours in evaluating carcinogenic risks to humans. IARC Technical Publication No. 39. IARC Press, LyonFrance 2003
   Google Scholar
• IARC. IARC Agent Page. 2002, http://193.51.164.11/cgi/iHound/Chem/iH_Chem_Frames.html [accessed 5 May 2005]
   Google Scholar
• Iatropoulos M. J., Williams G. M., Abdo K. M., Kari F. W., Hart R. W. Mechanistic studies on genotoxicity and carcinogenicity of salicylazosulfapyridine, an anti-inflammatory medicine. Exp. Toxicol. Pathol. 1997; 49: 15–28
   PubMedGoogle Scholar
• ICH (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use). Addendum to dose selection for carcinogenicity studies of pharmaceuticals–Addition of a limit dose and related notes (ICH-S1C(R)). 1997, http://www.fda.gov/cder/guidance/1858fnl.pdf
   Google Scholar
• ICH (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use). Guidelines on assessment of systemic exposure in toxicity studies. Fed. Reg. (Part XII) 1995a; 60(40)11264–11268
   Google Scholar
• ICH (International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use). Guidelines on dose selection for carcinogenicity studies of pharmaceuticals. Fed. Reg. (Part XII) 1995b; 60(40)11278–11281
   Google Scholar
• ILSI (International Life Sciences Institute). The relevance of the rat lung response to particle overload for human risk assessment: A workshop consensus report. ILSI Risk Science Institute Workshop Participants. Inhal. Toxicol. 2000; 12(1–2)1–17
   Google Scholar
• ILSI (International Life Sciences Institute). Principles for the Selection of Doses in Chronic Rodent Bioassays., JA Foran. ILSI Press, Washington, DC 1997
   Google Scholar
• ILSI/HESI (International Life Sciences Institute/Health and Environmental Sciences Institute). Alternatives to carcinogenicity testing project. Toxicol. Pathol. 2001; 29: 1–351
   PubMedGoogle Scholar
• Industrial Union Department v. American Petroleum Institute. 1980, 448 U.S. 607, 655
   Google Scholar
• IRIS (Integrated Risk Information System). Dichloromethane (CASRN 75–09-2). 2004, http://www.epa.gov/iris/subst/0070.htm (accessed March 10, 2004)
   Google Scholar
• Irvine C., Shand N., Fitzpatrick M., Alexander S. Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas. Am. J. Clin. Nutr. 1998; 68: 1462S–1465S
   Google Scholar
• Iwasaki K., Gleiser C. A., Masoro E. J., McMahan C. A., Seo E. J., Yu B. P. The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J. Gerontol. 1988; 43(1)B5–12
   Google Scholar
• Jacobson-Kram D., Sistare F. D., Jacobs A. C. Use of transgenic mice in carcinogenicity hazard assessment. Toxicol. Pathol. 2004; 32: 49–52
   PubMedGoogle Scholar
• Johnsen R. C., Baillie D. L. Formaldehyde mutagenesis of the eT1 balanced region in Caenorhabditis elegans: Dose-response curve and the analysis of mutational events. Mutat. Res. 1988; 201: 137–147
   PubMedGoogle Scholar
• Jonsson F., Johanson G. Physiologically based modeling of the inhalation kinetics of styrene in humans using a Bayesian population approach. Toxicol. Appl. Pharmacol. 2002; 179: 35–49
   PubMed Web of Science ®Google Scholar
• Kavlock R. J., Schmid J. E., Setzer R. W., Jr. A simulation study of the influence of study design on the estimation of benchmark doses for developmental toxicity. Risk Anal. 1996; 16: 399–410
   PubMed Web of Science ®Google Scholar
• Keenan K., Ballam G. C., Soper K., Laroque P., Coleman J., Dixit R. Diet, caloric intake, and the rodent bioassay. Toxicol. Sci. 1999; 52: 24–34
   PubMedGoogle Scholar
• Keller K. A. Laboratory animals in toxicology studies. Toxicology Testing Handbook: Principles, Applications, and Data Interpretation, D. Jacobson-Kram, K. A. Keller. Marcel Dekker, New York 2001
   Google Scholar
• Kelley G. E. The median lethal dose–design and estimation. Statistician 2001; 50: 41–50
   Google Scholar
• Kimbell J. S., Subramaniam R. P., Gross E. A., Schlosser P. M., Morgan K. T. Dosimetry modeling of inhaled formaldehyde: Comparisons of local flux predictions in the rat, monkey, and human nasal passages. Toxicol. Sci. 2001; 64: 100–110
   PubMed Web of Science ®Google Scholar
• Kitano H. Systems biology: A brief overview. Science 2002; 295: 1662–1664
   PubMed Web of Science ®Google Scholar
• Klaassen C. D., Hood A. M. Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism. Toxicol. Pathol. 2001; 29: 34–40
   PubMed Web of Science ®Google Scholar
• Kodell R., Turturro A. Risk assessment implications of mechanistic models' prediction of low-dose nonlinearity of liver tumor risk for mice fed fumonisin B1. Nonlinearity Biol. Toxicol. Med. 2004; 2: 1–9
   PubMedGoogle Scholar
• Kodell R., Young J., Delongchamp R., Turturro A., Chen J., Gaylor D., Howard P., Zheng Q. A mechanistic approach to modeling the risk of liver tumors in mice exposed to fumonisin B1 in the diet. Food Addit. Contam. 2001; 18: 237–253
   PubMed Web of Science ®Google Scholar
• Kohara A., Suzuki T., Honma M., Oomori T., Ohwada T., Hayashi M. Dinitropyrenes induce gene mutations in multiple organs of the lambda/lacZ transgenic mouse (Muta Mouse). Mutat. Res. 2002; 515(1–2)73–83
   PubMedGoogle Scholar
• Kramer J. A., Curtiss S. W., Kolaja K. L., Alden C. L., Blomme E. A., Curtiss W. C., Davila J. C., Jackson C. J., Bunch R. T. Acute molecular markers of rodent hepatic carcinogenesis identified by transcription profiling. Chem. Res. Toxicol. 2004; 17: 463–470
   PubMed Web of Science ®Google Scholar
• Kubic V. L., Anders M. W., Engel R. R., Barlow C. H., Caughey W. S. Metabolism of dihalomethanes to carbon monoxide. I. In vivo studies. Drug Metab. Dispos. 1974; 2: 53–57
   PubMed Web of Science ®Google Scholar
• Kubo Y., Klimek F., Kikuchi Y., Bannasch P., Hino O. Early detection of Knudson's two-hits in preneoplastic renal cells of the Eker rat model by the laser microdissection procedure. Cancer Res. 1995; 55(5)989–990
   PubMedGoogle Scholar
• Laib R. J., Klein K. P., Bolt H. M. The rat liver foci bioassay: I. Age-dependence of induction by vinyl chloride of ATPase-deficient foci. Carcinogenesis 1985; 6(1)65–68
   PubMedGoogle Scholar
• Lau S. S., Monks T. J., Everitt J. I., Kleymenova E., Walker C. L. Carcinogenicity of a nephrotoxic metabolite of the “nongenotoxic” carcinogen hydroquinone. Chem. Res. Toxicol. 2001; 14(1)25–33
   PubMedGoogle Scholar
• Leahy D. E. Progress in simulation modelling for pharmacokinetics. Curr. Topics Med. Chem. 2003; 3: 1257–1268
   PubMed Web of Science ®Google Scholar
• Leakey J., Seng J., Allaben W. Influence of body weight, diet, and stress on aging, survival and pathological endpoints in rodents: Implications for toxicity testing and risk assessment. Regul. Res. Perspect. 2004; 4(1)1–29
   Google Scholar
• Leder A., Kuo A., Cardiff R., Sinn E., Leder P. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA 1990; 87: 9178–9182
   PubMed Web of Science ®Google Scholar
• Lee B. M., Yoo S. D., Kim S. A proposed methodology of cancer risk assessment modeling using biomarkers. J. Toxicol. Environ. Health A 2002; 65(5–6)341–354
   PubMed Web of Science ®Google Scholar
• Lingas R. I., Matthews S. G. A short period of maternal nutrient restriction in late gestation modifies pituitary-adrenal function in adult guinea pig offspring. Neuroendocrinology 2001; 73(5)302–311
   PubMedGoogle Scholar
• Luebeck E. G., Buchmann A., Stinchcombe S., Moolgavkar S. H., Schwarz M. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: A quantitative analysis of experimental data using a stochastic model. Toxicol. Appl. Pharmacol. 2000; 167(1)63–73
   PubMedGoogle Scholar
• Lutz W. K., Kopp-Schneider A. Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay. Toxicol. Sci. 1999; 49: 110–115
   PubMed Web of Science ®Google Scholar
• Magari S. R., Hauser R., Schwartz J., Williams P. L., Smith T. J., Christiani D. C. Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation 2001; 104: 986–991
   PubMed Web of Science ®Google Scholar
• Mast R. W., Yu C. P., Oberdorster G., McConnell E. E., Utell M. J. A retrospective review of the carcinogenicity of refractory ceramic fiber in two chronic Fischer 344 rat inhalation studies: An assessment of the MTD and implications for risk assessment. Inhal. Toxicol. 2000; 12(12)1141–1172
   PubMed Web of Science ®Google Scholar
• Meek M. E., Bucher J. R., Cohen S. M., Dellarco V., Hill R. N., Lehman-McKeeman L. D., Longfellow D. G., Pastoor T., Seed J., Patton D. E. A framework for human relevance analysis of information on carcinogenic modes of action [Case Study D]. Crit. Rev. Toxicol. 2003a; 33(6)614–620
   Google Scholar
• Meek M. E., Bucher J. R., Cohen S. M., Dellarco V., Hill R. N., Lehman-McKeeman L. D., Longfellow D. G., Pastoor T., Seed J., Patton D. E. A framework for human relevance analysis of information on carcinogenic modes of action [Case Study E]. Crit. Rev. Toxicol. 2003b; 33(6)620–624
   Google Scholar
• Merk O., Speit G. Significance of formaldehyde-induced DNA-protein crosslinks for mutagenesis. Environ. Mol. Mutagen. 1998; 32: 260–268
   PubMed Web of Science ®Google Scholar
• Miller F. J. Dosimetry of particles in laboratory animals and humans in relationship to issues surrounding lung overload and human health risk assessment: A critical review. Inhal. Toxicol. 2000; 12(1–2)19–57
   PubMed Web of Science ®Google Scholar
• Miyanishi K., Takayama T., Ohi M., Hayashi T., Nobuoka A., Nakajima T., Takimoto R., Kogawa K., Kato J., Sakamaki S., Niitsu Y. Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterology 2001; 121(4)865–874
   PubMed Web of Science ®Google Scholar
• Moller P., Wallin H., Vogel U., Autrup H., Risom L., Hald M. T., Daneshvar B., Dragsted L. O., Poulsen H. E., Loft S. Mutagenicity of 2-amino-3-methylimidazao[4,5-f]quinoline in colon and liver of Big Blue rats: Role of DNA adducts, strand breaks, DNA repair and oxidative stress. Carcinogenesis 2002; 23(8)1379–1385
   PubMedGoogle Scholar
• Monticello T. M., Swenberg J. A., Gross E. A., Leininger J. R., Kimbell J. S., Seilkop S., Starr T. B., Gibson J. E., Morgan K. T. Correlation of regional and nonlinear formaldehyde-induced nasal cancer with proliferating populations of cells. Cancer Res. 1996; 56: 1012–1022
   PubMed Web of Science ®Google Scholar
• Moolgavkar S. H., Luebeck E. G., Turim J., Hanna L. Quantitative assessment of the risk of lung cancer associated with occupational exposure to refractory ceramic fibers. Risk. Anal. 1999; 19: 599–611
   PubMed Web of Science ®Google Scholar
• Moolgavkar S. H., Luebeck E. G., Buchmann A., Bock K. W. Quantitative analysis of enzyme-altered liver foci in rats initiated with dethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachloro-p-dioxin. Toxicol. Appl. Pharmacol. 1996; 138(1)31–42
   PubMedGoogle Scholar
• Morrow P. E. Dust overloading of the lungs: update and appraisal. Toxicol. Appl. Pharmacol. 1992; 113(1)1–12
   PubMed Web of Science ®Google Scholar
• Moschos S., Mantzoros C. The role of IGF system in cancer: From basic to clinical studies and clinical applications. Oncology 2002; 63: 317–332
   PubMed Web of Science ®Google Scholar
• Mossman B. T. Mechanisms of action of poorly soluble particulates in overload-related lung pathology. Inhal. Toxicol. 2000; 12(1–2)141–148
   PubMed Web of Science ®Google Scholar
• Newberne P., Broitman S., Schrager T. Esophageal carcinogenesis in the rat: zinc deficiency, DNA methylation and alkyltransferase activity. Pathobiology 1997; 65: 253–263
   PubMedGoogle Scholar
• Newton R. K., Aardema M., Aubrecht J. The utility of DNA microarrays for characterizing genotoxicity. Environ. Health Perspect. 2004; 112: 420–422
   PubMed Web of Science ®Google Scholar
• NRC (National Research Council). Estimating the Public Health Benefits of Proposed Air Pollution Regulations, AW Hayes. National Academy Press, Washington, DC 2002, October
   Google Scholar
• NTP (National Toxicology Program). NTP 10th Report on Carcinogens, Research Triangle Park, NC. Federal Register, AW Hayes. Raven Press, New York 2002; 67 NO. 183: 59301–59303, September 20, 2002
   Google Scholar
• NTP (National Toxicology Program). Toxicology and carcinogenesis studies of dichloromethane in the F-344/N rats and B6C3F1 Mice. Principles and Methods of Toxicology, AW Hayes. National Toxicology Program, Research Triangle Park, NC 1986, NTP-TR-306. (January 1986) http://ntp-server.niehs.nih.gov/ntp/htdoc/LT_rpts/tr306.pdf
   Google Scholar
• Oberdorster G. The NTP talc inhalation study: A critical appraisal focused on lung particle overload. Regul. Toxicol. Pharmacol. 1995; 21(2)233–241
   PubMedGoogle Scholar
• O'Donovan M. R., Mee C. D. Formaldehyde is a bacterial mutagen in a range of Salmonella and Escherichia indicator strains. Mutagenesis 1993; 8: 577–581
   PubMedGoogle Scholar
• OECD (Organization for Economic Cooperation and Development). Guidance notes for analysis and evaluation of chronic toxicity and carcinogenicity studies. OECD Environment and Safety Publications Series on Testing and Assessment No. 35 and Series on Pesticides No. 14. AW Hayes. Raven Press, ParisFrance 2002
   Google Scholar
• Oghiso Y., Yamada Y. Pathogenic process of lung tumors induced by inhalation exposures of rats to plutonium dioxide aerosols. Radiat. Res. 2000; 154: 253–260
   PubMedGoogle Scholar
• OMB (Office of Management and Budget). Guidelines to standardize measures of costs and benefits and the format of accounting statements. Memorandum from J. J. Lew. March 22, (2000). 1994, http://www.whithouse.gov/omb/memoranda/m00-08.pdf
   Google Scholar
• Pauluhn J., Mohr U. Inhalation studies in laboratory animals–Current concepts and alternatives. Toxicol. Pathol. 2000; 28(5)734–753
   PubMed Web of Science ®Google Scholar
• Peraino C., Staffeldt E. F., Carnes B. A., Ludeman V. A., Blomquist J. A., Vesselinovitch S. D. Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res. 1984; 44(8)3340–3347
   PubMedGoogle Scholar
• Peters E., Liu E., Verrier R. L., Schwartz J., Gold D. R., Mittleman M., Baliff J., Oh J. A., Allen G., Monahan K., Dockery D. W. Air pollution and incidence of cardiac arrhythmia. Epidemiology 2000; 11: 11–17
   PubMed Web of Science ®Google Scholar
• Phillips D. I. Fetal growth and programming of the hypothalamic-pituitary-adrenal axis. Clin. Exp. Pharmacol. Physiol. 2001; 28(11)967–970
   PubMedGoogle Scholar
• Pope C. A., III, Eatough D. J., Gold D. R., Pang Y., Nielson K. R., Nath P., Verrier R. L., Kanner R. E. Acute exposure to environmental tobacco smoke and heart rate variability. Environ. Health Perspect. 2001; 109(7)711–716
   PubMed Web of Science ®Google Scholar
• Portier C. Personal communications while reviewing analyses of cholinesterase-inhibiting agents under the Food Quality Protection Act. AW Hayes. National Toxicology Program/National Institute for Environmental Health Sciences, Research Triangle Park, NC 2002
   Google Scholar
• Portier C. J., Sherman C. D., Kohn M., Edler L., Kopp-Schneider A., Maronpot R. M., Lucier G. Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD. Toxicol. Appl. Pharmacol. 1996; 138(1)20–30
   PubMed Web of Science ®Google Scholar
• Portier C. J., Edler L. Two-stage models of carcinogenesis, classification of agents, and design of experiments. Fundam. Appl. Toxicol. 1990; 14(3)444–460
   PubMedGoogle Scholar
• Portier C. J., Hoel D. G. Design of animal carcinogenicity studies for goodness-of-fit of multistage models. Fundam. Appl. Toxicol. 1984; 4(6)949–959
   PubMedGoogle Scholar
• Portier C., Hoel D. Optimal design of the chronic animal bioassay. Toxicol. Environ. Health 1983; 12(1)1–19
   PubMed Web of Science ®Google Scholar
• Pritchard J. B., French J. E., Davis B. J., Haseman J. K. The role of transgenic mouse models in carcinogen identification. Environ. Health Perspect. 2003; 111(4)444–454
   PubMed Web of Science ®Google Scholar
• Rhomberg L. R. Seeking optimal design for animal bioassay studies. Toxicol. Sci. 2005; 84: 1–3
   PubMedGoogle Scholar
• Roland M., Balant M., Peck C. Physiologically based pharmacokinetics in drug development and regulatory science: A workshop report (Georgetown University, Washington, D.C., May 29–30, 2002). AAPS Pharm. Sci. 2004; 6: 1–12
   Google Scholar
• Rowland I., Faughnan M., Hoey L., Wahala K., Williamson G., Cassidy A. Bioavailability of phytoestrogens. Br. J. Nutr. 2003; 89(Suppl. 1)S45–58
   PubMed Web of Science ®Google Scholar
• Rushmore T. H., Kong A. N. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 2002; 3: 481–490
   PubMed Web of Science ®Google Scholar
• Sachs K., Perez O., Pe'er D., Lauffenburger D. A., Nolan G. P. Causal protein-signaling networks derived from multiparameter single-cell data. Science 2005; 308: 523–529
   PubMed Web of Science ®Google Scholar
• Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., Katuski M. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 1990; 5: 1195–1200
   PubMedGoogle Scholar
• Savolainen K. Commentary: the use of maximum tolerated dose in rodent carcinogenicity bioassays and its relevance to human risk assessment. Hum. Exp. Toxicol. 1997; 16(4)190–192
   PubMedGoogle Scholar
• Schlosser P. M., Lilly P. D., Conolly R. B., Janszen D. B., Kimbell J. S. Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment, DNA-protein cross-link dosimetry model to estimate human equivalent doses. Risk Anal. 2003; 23(3)473–487
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann R., Grast-Knapp B., Bursch W. Dose-response and threshold effects in cytotoxicity and apoptosis. Mutat. Res. 2000; 464: 13–18
   PubMed Web of Science ®Google Scholar
• Seilkop S. K. The effect of body weight on tumor incidence and carcinogenicity testing in B6C3F1 mice and F344 rats. Fundam. Appl. Toxicol. 1995; 24: 247–259
   PubMedGoogle Scholar
• Serota D. G., Thakur A. K., Ulland B. M., Kirschman J. C., Brown N. M., Coots R. H., Morgareidge K. A two-year drinking-water study of dichloromethane in rodents. II. Mice. Food Chem. Toxicol. 1986; 24: 959–963
   PubMed Web of Science ®Google Scholar
• Shuker D. The enemy at the gates? DNA adducts as biomarkers of exposure to exogenous and endogenous genotoxic agents. Toxicol. Lett. 2002; 134(1–3)51
   PubMedGoogle Scholar
• Sisk S. C., Pluta L. J., Bond J. A., Reciio L. Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene. Carcinogenesis 1994; 15(3)471–477
   PubMedGoogle Scholar
• Sistare F. D., Jacobs A. C. Use of transgenic animals in regulatory carcinogenicity evaluations. Alternative Toxicological Methods, H Salem, SA Katz. CRC Press, Boca Raton, FL 2003; 391–412
   Google Scholar
• Sistare F. D., Thompson K. L., Honchel R., DeGeorge J. Evaluation of the Tg·AC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals–Practical pointers, mechanistic clues and new questions. Int. J. Toxicol. 2002; 21: 65–79
   PubMedGoogle Scholar
• Slikker W. J.r., Andersen M. E., Bogdanffy M. S., Bus J. S., Cohen S. D., Conolly R. B., David R. M., Doerrer N. G., Dorman D. C., Gaylor D. W., Hattis D., Rogers J. M., Setzer R. W., Swenberg J. A., Wallace K. Dose-dependent transitions in mechanisms of toxicity. Toxicol. Appl. Pharmacol. 2004a; 201: 203–225
   PubMed Web of Science ®Google Scholar
• Slikker W., Jr, Andersen M. E., Bogdanffy M. S., Bus J. S., Cohen S. D., Conolly R. B., David R. M., Doerrer N. G., Dorman D. C., Gaylor D. W., Hattis D., Rogers J. M., Setzer R. W., Swenberg J. A., Wallace K. Dose-dependent transitions in mechanisms of toxicity: Case studies. Toxicol. Appl. Pharmacol. 2004b; 201: 226–294
   PubMed Web of Science ®Google Scholar
• Smith G. Scientific review of chronic rodent bioassays. Criteria for Maximum Tolerated Dose (MTD) attainment: clinical pathology- and pathology-related endpoints. Liver and kidney. Unpublished draft, submitted to Pest Management Regulatory Agency, OttawaCanada 2002
   Google Scholar
• Smith G. IARC Agent Page. Unpublished draft, submitted to Pest Management Regulatory Agency, OttawaCanada 2003
   Google Scholar
• Smith G. Scientific review of chronic rodent bioassays. Criteria for Maximum Tolerated Dose (MTD) attainment: clinical pathology- and pathology-related endpoints. Reproductive system. Unpublished draft, submitted to Pest Management Regulatory Agency, OttawaCanada 2004
   Google Scholar
• Sontag J. M., Page N. P., Saffiotti U. Guidelines for carcinogen bioassay in small rodents. Department of Health, Education, and Welfare, National Cancer Institute, Division of Cancer Cause & Prevention, Carcinogenesis Program, Bethesda, MD 1976, DHEW Publication No. (NIH) 76–801
   Google Scholar
• Soria J. C., Rodriguez M., Liu D. D., Lee J. J., Hong W. K., Mao L. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res. 2002; 62(2)351–355
   PubMed Web of Science ®Google Scholar
• Spindel E. Sulfasalazine and folate deficiency. J. Am. Med. Assoc. 1983; 250: 900
   Google Scholar
• Swartout J. C., Price P. S., Dourson M. L., Carlson-Lynch H. L., Keenan R. E. A probabilistic framework for the reference dose (probabilistic RfD). Risk Anal. 1998; 18: 271–282
   PubMed Web of Science ®Google Scholar
• Teeguarden J. G., Dragan Y. P., Singh J., Vaughan J., Xu Y. H., Goldsworthy T., Pitot H. C. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats. Toxicol. Sci. 1999; 51(2)211–223
   PubMedGoogle Scholar
• Thompson K. L., Afshari C. A., Amin R. P., Bertram T. A., Car B., Cunningham M., Kind C., Kramer J. A., Lawton M., Mirsky M., Naciff J. M., Oreffo V., Pine P. S., Sistare F. D. Identification of platform-independent gene expression markers of cisplatin nephrotoxicity. Environ. Health Perspect. 2004; 112(4)488–494
   PubMedGoogle Scholar
• Turturro A., Hass B., Hart R., Allaben W. Body weight impact on spontaneous and agent-induced diseases in chronic bioassays. Int. J. Toxicol. 1998a; 17: 79–100
   Google Scholar
• Turturro A., Leakey J., Allaben W., Hart R. Modulation of the carcinogenic response by caloric restriction. Nutrition and Chemical Toxicity, C Ioannides. J Wiley and Sons, SussexUK 1998b; 201–218
   Google Scholar
• Turturro A., Duffy P., Hart R., Allaben W. Rationale for the use of dietary control in toxicity studies–B6C3F1 mouse. Toxicol. Pathol. 1996; 24: 769–775
   PubMed Web of Science ®Google Scholar
• Turturro A., Duffy P., Hart R. The effect of caloric modulation on toxicity studies. Dietary Restriction: Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies, R. Hart, D. Neuman, R. Robertson. ILSI Press, Washington, DC 1995; 79–98
   Google Scholar
• Turturro A., Duffy P., Hart R. Modulation of toxicity by diet and dietary macronutrient restriction. Mutat. Res. 1993; 295: 151–164
   PubMed Web of Science ®Google Scholar
• Ulrich C., Robien K., Sparks R. Pharmacogenetics and folate metabolism–A promising direction. Pharmacogenomics 2002; 3: 299–313
   PubMed Web of Science ®Google Scholar
• U.S. EPA (Environmental Protection Agency). Guidelines for carcinogen risk assessment (EPA/630/P-03/001F). Risk Assessment Forum, Washington, DC 2005
   Google Scholar
• U.S. EPA (Environmental Protection Agency). Rodent Carcinogenicity Studies: Dose Selection and Evaluation. Health Effects Division (HED) Interim Guidance Document G2003.02. Office of Pesticide Programs, Washington, DC 2003
   Google Scholar
• U.S. EPA (Environmental Protection Agency). A review of the reference dose and reference concentration processes (EPA/600/P-02/002F). Risk Assessment Forum, Washington, DC 2002
   Google Scholar
• U.S. EPA (Environmental Protection Agency). Trichloroethylene health risk assessment: Synthesis and characterization, External Review Draft, (EPA/600/P-01/002A). National Center for Environmental Assessment, Office of Research and Development, Washington, DC 2001a
   Google Scholar
• U.S. EPA (Environmental Protection Agency). Risk assessment guidance for Superfund: Volume III, Part, A., Process for conducting probabilistic risk assessment. Office of Emergency and Remedial Response, Washington, DC 2001b, EPA/540-R-02–002; PB2002 963302; http://www.epa.gov/superfund/RAGS3A/index.htm, December
   Google Scholar
• U.S. EPA (Environmental Protection Agency). IRIS listing for vinyl chloride (CASRN 75–01-4). 2000, http://www.epa.gov/iris/subst/1001.htm (accessed Nov. 28, 2004)
   Google Scholar
• U.S. EPA (Environmental Protection Agency). Health effects test guidelines. OPPTS 870.4300. Combined chronic toxicity/carcinogenicity. 1998, EPA 712-C-98–212
   Google Scholar
• U.S. EPA (Environmental Protection Agency). Atlas of dermal lesions. Office of Pesticides and Toxic Substances. 1990, Document 20T-2004, August
   Google Scholar
• U.S. EPA (Environmental Protection Agency). Summary of the EPA Workshop on Carcinogenesis Bioassay via the Dermal Route, April 28–29, 1987, Washington, DC. EPA 560/6–89-002, Springfield, VA 1989a, available from NTIS
   Google Scholar
• U.S. EPA (Environmental Protection Agency). Summary of the Second EPA Workshop on Carcinogenesis Bioassay via the Dermal Route, May 18–19, 1988, Research Triangle Park, NC. EPA 560/6–89-003, Springfield, VA 1989b, available from NTIS
   Google Scholar
• U.S. EPA (Environmental Protection Agency). Health assessment document for dichloromethane (methylene chloride). 1985a, EPA/600 8–82 004F
   Google Scholar
• U.S. EPA (Environmental Protection Agency). Addendum to the health assessment document for dichloromethane (methylene chloride): Updated carcinogenicity assessment of dichloromethane (methylene chloride). 1985b, EPA/600 8–82 004FF
   Google Scholar
• U.S. EPA (Environmental Protection Agency). Health assessment document for dichloromethane (methylene chloride). 1983, EPA/600 8–82 004B
   Google Scholar
• U.S. Interagency Staff Group on Carcinogens. Chemical carcinogens: A review of the science and its associated principles. Environ. Health Perspect. 1986; 67: 201–282
   PubMedGoogle Scholar
• Van Kreijl C. F., McAnulty P. A., Beems R. B., Vynckier A., van Steeg H., Fransson-Steen R., Alden C. L., Forster R., van der Laan J.-W., Vandenberghe J. Xpa and Xpa/p53+/− knockout mice: Overview of available data. Toxicol. Pathol. 2001; 29: 117–127
   PubMed Web of Science ®Google Scholar
• Van Steeg H., de Vries A., van Oostrom C. T.M., van Benthem J., Beems R. B., van Kreijl C. F. DNA repair-deficient Xpa and Xpa/p53+/− knockout mice: Nature of the models. Toxicol. Pathol. 2001; 29: 109–116
   PubMedGoogle Scholar
• Venkatachalam S., Tyner S. D., Pickering C. R., Boley S., Recio L., Frech J. E., Donehower L. A. Is p53 haplo insufficient for tumor suppression? Implications for the p53+/− mouse model in carcinogenicity testing. Toxicol. Pathol. 2001; 29: 147–154
   PubMedGoogle Scholar
• Verma M., Wright G. L., Jr., Hanash S. M., Gopal-Srivastava R., Srivastava S. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann. NY Acad. Sci. 2001; 945: 103–115
   PubMed Web of Science ®Google Scholar
• Vickers M. I.I., Breier B.I.I., Cutfield W. S., Hofman P. L., Gluckman P. D. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am. J. Physiol. Endocrinol. Metab. 2000; 279(1)E83–87
   PubMed Web of Science ®Google Scholar
• von Knebel Doeberitz M., Lacroix J. Nucleic acid based techniques for the detection of rare cancer cells in clinical samples. Cancer Metastasis Rev. 1999; 18(1)43–64
   PubMedGoogle Scholar
• Warheit D. B., Hansen J. F., Yuen I. S., Kelly D. P., Snajdr S. I., Hartsky M. A. Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. Toxicol. Appl. Pharmacol. 1997; 145(1)10–22
   PubMed Web of Science ®Google Scholar
• Watanabe P. G., Gehring P. J. Dose-dependent fate of vinyl chloride and its possible relationship to oncogenicity in rats. Environ. Health Perspect. 1976; 17: 145–152
   PubMed Web of Science ®Google Scholar
• Weisburger E. K. Techniques for carcinogenicity studies. Cancer Res. 1981; 41(9 Pt 2)3690–3694
   PubMedGoogle Scholar
• Weisburger J. H., Weisburger E. K. Tests for chemical carcinogens. Methods in Cancer Research, H Busch. Academic Press, New York 1967; 1
   Google Scholar
• Weller E. A., Catalano P. J., Williams P. L. Implications of developmental toxicity study design for quantitative risk assessment. Risk Anal. 1995; 15: 567–574
   Web of Science ®Google Scholar
• WHO (World Health Organization). Global Assessment of the State-of-the-Science of Endocrine Disruptors. WHO/IPCS/EDC/02.2, Geneva 2002
   Google Scholar
• WHO (World Health Organization), International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 88. Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol. WHO Press, World Health Organization, Geneva 2006
   Google Scholar
• Williams G. M., Iatropoulos M. J. Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity. Toxicol. Pathol. 2002; 30: 41–53
   PubMed Web of Science ®Google Scholar
• Wistuba I. I., Lam S., Behrens C., Virmani A. K., Fong K. M., LeRiche J., Samet J. M., Srivastava S., Minna J. D., Gazdar A. F. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 1997; 89(18)1366–1373
   PubMedGoogle Scholar
• Wistuba I. I., Behrens C., Milchgrub S., Bryant D., Hung J., Minna J. D., Gazdar A. F. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999a; 18(3)643–650
   PubMed Web of Science ®Google Scholar
• Wistuba I. I., Behrens C., Virmani A. K., Milchgrub S., Syed S., Lam S., Mackay B., Minna J. D., Gazdar A. F. Allelic losses at chromosome 8p21–23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res. 1999b; 59(8)1973–1979
   PubMedGoogle Scholar
• Wolff G. L., Gaylor D. W., Blackwell B. N., Moore G. E. Bladder and liver tumorigenesis induced by 2-acetylaminofluorene in different F1 mouse hybrids: Variation within genotypes and effects of using more than one genotype on risk assessment. J. Toxicol. Environ. Health 1991; 33(3)327–348
   PubMed Web of Science ®Google Scholar
• Youssef A. F., Borellini F., Jacobson-Kram D., Fort F. Analysis for loss of heterozygosity (LOH) of p53 allele in tumors derived from p53+/− and CD-1 mice following repeated subcutaneous injections of solutions containing antioxidants. Environ. Mol. Mutagen. 2001; 37: 27–30
   PubMedGoogle Scholar